Capricor Therapeutics, Inc.
CAPRNasdaqCIK 1133869HealthcareFiscal year ends Dec 31
Reports and events: 337 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-2413:25 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-100071 |
| 2026-08-1420:46 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-097294 |
| 2026-08-1320:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-095908 |
| 2026-07-3020:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-088667 |
| 2026-07-2914:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-087891 |
| 2026-07-1421:06 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001104659-26-083559 |
| 2026-06-2621:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-078327 |
| 2026-06-0820:05 ET | 8-K | 5.07 Shareholder vote results | 0001104659-26-071364 |
| 2026-05-1321:20 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-060382 |
| 2026-05-1220:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-059380 |
| 2026-05-0720:40 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-057221 |
| 2026-04-1020:31 ET | DEF 14A | Proxy statementPeriod 2026-06-04 | 0001104659-26-042070 |
| 2026-03-1721:00 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-029580 |
| 2026-03-1220:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-027037 |
| 2026-03-1015:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-025657 |
| 2025-12-0522:07 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-118934 |
| 2025-12-0314:29 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-117981 |
| 2025-12-0312:21 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-117947 |
| 2025-11-1022:20 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-109298 |
| 2025-11-1021:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-109119 |
| 2025-08-1121:25 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-011084 |
| 2025-08-1120:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-011047 |
| 2025-07-1110:35 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-009186 |
| 2025-05-2713:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001558370-25-008145 |
| 2025-05-1420:30 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-007770 |
| 2025-05-1320:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-007574 |
| 2025-04-0821:15 ET | DEF 14A | Proxy statementPeriod 2025-05-22 | 0001558370-25-004610 |
| 2025-04-0821:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001558370-25-004605 |
| 2025-03-2620:15 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-003707 |
| 2025-03-1920:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-003304 |
| 2025-03-0412:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-002097 |
| 2025-01-0219:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-000010 |
| 2024-11-1421:30 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-015730 |
| 2024-11-1321:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-015519 |
| 2024-10-1710:01 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-013357 |
| 2024-10-1620:25 ET | 8-K | 2.02 Results of operations; 8.01 Other events | 0001558370-24-013344 |
| 2024-10-0913:16 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-013207 |
| 2024-09-2420:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-012983 |
| 2024-09-1713:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-012836 |
| 2024-08-0821:00 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001558370-24-011638 |
| 2024-08-0720:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-011350 |
| 2024-05-1521:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001558370-24-008313 |
| 2024-05-1521:00 ET | 8-K | 5.07 Shareholder vote results | 0001558370-24-008310 |
| 2024-05-1413:00 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001558370-24-008072 |
| 2024-05-1320:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-007958 |
| 2024-04-2913:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-006020 |
| 2024-04-0121:35 ET | DEF 14A | Proxy statementPeriod 2024-05-14 | 0001558370-24-004399 |
| 2024-03-1112:30 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001558370-24-002861 |
| 2024-02-2921:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-002183 |
| 2024-01-1114:00 ET | 8-K | 8.01 Other events | 0001558370-24-000197 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:05 ET. Listed shows no prices and gives no investment advice.